No Data
LIFETECH SCI (01302.HK): Ruan Xingmei has been appointed as Executive Director.
Gelonghui, December 12丨LIFETECH SCI (01302.HK) announced that Ruan Xingmei has been appointed as the executive Director of the company, effective from December 12, 2024.
Express News | LifeTech Scientific - Ruan Xingmei Appointed Executive Director
LifeTech Scientific Corporation's (HKG:1302) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
LifeTech Scientific (HKG:1302) Stock Falls 6.0% in Past Week as Three-year Earnings and Shareholder Returns Continue Downward Trend
Lifetech Sci (01302.HK): IBS absorbable drug-eluting coronary stent system announces the one-year follow-up results of Phase III clinical study.
Great Wall Power October 31st | Lifetech Sci (01302.HK) announced that the self-developed IBS absorbable drug-eluting coronary artery brackets system ("IBS coronary artery brackets") has successfully completed the Phase III clinical trial follow-up of one year, and on October 29, 2024, local time in the usa, Director Song Lei of the Fuwai Hospital of the Chinese Academy of Medical Sciences, on behalf of Academician Gao Runlin and all researchers, first presented the one-year major endpoint follow-up results of the Phase III clinical trial of IBS coronary artery brackets at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting to the global audience for the first time in 2024.
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
LifeTech Scientific Corporation (HKG:1302) May Have Run Too Fast Too Soon With Recent 27% Price Plummet
